Case Study

Evaluating And Improving Apheresis Material Cryopreservation Processes

Source: Jefferson Institute for Bioprocessing (JIB)
Cryopreservation GettyImages-172640159

Autologous cell therapies have demonstrated ground-breaking clinical outcomes recently, such as the success of chimeric antigen receptor T cell therapeutics in treating patients with hematologic cancers. As more products advance toward FDA approval and commercialization, addressing the major manufacturing challenges is drawing the focus of the industry.

This study examines a Philadelphia-based biotechnology company with an analog of the CAR technology aiming to evaluate process improvement around cryopreservation of apheresis material. While cryopreservation of apheresis is a well-established practice offering many advantages, cell clumping can be observed upon thawing, an occurrence which can potentially cause transduction issues and may hinder cell growth and subsequent immunophenotyping.

Cryopreservation and the composition of freezing media on T cell proliferation remains understudied and requires further attention as the area of autologous cell therapy matures and related products enter the market. Learn more about the process evaluation and possible improvements for cryomediums as well as sample shipment, storage temperature, and handling of the studied markers and functional properties of T cells.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online

Jefferson Institute for Bioprocessing (JIB)